An in vivo study conducted on Pharmactive Biotech’s ABG10+, with high SAC and polyphenols, showed improvements to several cardiovascular health metrics in rats.
The mushroom-based ingredient can make licensed support claims on immune function, bone health, and general well-being in both adults and children in the Canadian marketplace.
Due to COVID-19, FDA announced that it will begin conducting its inspection activities electronically for the remainder of the public health emergency.